Medical school lecture criticized for minimizing opioid risks

Taking stock of the drug industry, from the lab to the medicine chest

February 7, 2024 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

ERIC BARADAT/AFP/Getty Images STAT+ | Years into an addiction crisis, a med school lecture still minimized opioid risks "We've seen what happens when doctors are misled about opioids," said Adriane Fugh-Berman of Georgetown University. By Ed Silverman STAT+ | RayzeBio co-founder, industry veterans launch new biotech VC with $310 million The firm, which plans to launch six or seven biotechs with this first fund, already has four in development. By Allison DeAngelis STAT+ | AI can speed up drug discovery but don't expect it to cure cancer, yet AI models promise to identify new disease targets, design better drugs, and improve clinical trials, but experts say major breakthroughs are a long way off. By Casey Ross

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser